|
US8992984B1
(en)
|
2009-10-21 |
2015-03-31 |
Stc.Unm |
Protocells and their use for targeted delivery of multicomponent cargos to cancer cells
|
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
ES3005233T3
(en)
|
2010-10-01 |
2025-03-14 |
Modernatx Inc |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
|
EP2701686A4
(en)
|
2011-04-28 |
2014-11-05 |
Stc Unm |
LIPID BINCHES SUPPORTED ON POROUS NANOPARTICLES (PROTOCELLS) FOR TARGETED ADMINISTRATION, AND METHODS OF USE THEREOF
|
|
JP2014523444A
(ja)
|
2011-07-19 |
2014-09-11 |
エスティーシー． ユーエヌエム |
癌の炎症性環境に基づいて治療用積載物を放出する、腹腔内投与されるナノ担体
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
EP2763701B1
(en)
|
2011-10-03 |
2018-12-19 |
Moderna Therapeutics, Inc. |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
|
JP2015501844A
(ja)
|
2011-12-16 |
2015-01-19 |
モデルナ セラピューティクス インコーポレイテッドＭｏｄｅｒｎａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
修飾ヌクレオシド、ヌクレオチドおよび核酸組成物
|
|
WO2013151663A1
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of membrane proteins
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
US9273305B1
(en)
|
2012-04-25 |
2016-03-01 |
Sandia Corporation |
Cell-based composite materials with programmed structures and functions
|
|
CN105050708A
(zh)
|
2012-11-14 |
2015-11-11 |
格雷斯公司 |
含有生物活性材料与无序无机氧化物的组合物
|
|
HUE044605T2
(hu)
*
|
2012-11-16 |
2019-11-28 |
Univ College Cardiff Consultants Ltd |
RP/SP gemcitabin-[fenil-(benziloxi-L-alaninil)]-foszfát keveréke
|
|
ES2921623T3
(es)
|
2012-11-26 |
2022-08-30 |
Modernatx Inc |
ARN modificado terminalmente
|
|
EP4378461A3
(en)
|
2013-03-05 |
2024-09-11 |
The Regents of University of California |
Lipid bilayer coated mesoporous silica nanoparticles with a high loading capacity for one or more anticancer agents
|
|
US10258698B2
(en)
|
2013-03-14 |
2019-04-16 |
Modernatx, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
WO2014201276A1
(en)
*
|
2013-06-12 |
2014-12-18 |
The Methodist Hospital |
Polycation-functionalized nanoporous silicon carrier for systemic delivery of gene silencing agents
|
|
WO2015013352A2
(en)
*
|
2013-07-25 |
2015-01-29 |
Patel Hasmukh B |
Nucleoside phosphoramidates and phosphoramidites
|
|
US20160194625A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
WO2015034925A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
WO2015042268A1
(en)
*
|
2013-09-18 |
2015-03-26 |
Stc.Unm |
Core and surface modification of mesoporous silica nanoparticles to achieve cell specific targeting in vivo
|
|
EP3046543A1
(en)
*
|
2013-09-18 |
2016-07-27 |
Stc.Unm |
Torroidal mesoporous silica nanoparticles (tmsnps) and related protocells
|
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
KR20160067219A
(ko)
|
2013-10-03 |
2016-06-13 |
모더나 세라퓨틱스, 인코포레이티드 |
저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드
|
|
US9474720B2
(en)
|
2013-11-04 |
2016-10-25 |
BioPharmX, Inc. |
Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
|
|
US20170002413A1
(en)
*
|
2014-01-17 |
2017-01-05 |
The University Of Tokyo |
Molecule associated with onset of gout, and method and kit for evaluating diathesis of uric acid-related diseases and inflammation-related diseases, and inspection object and drug
|
|
EP3169693B1
(en)
|
2014-07-16 |
2022-03-09 |
ModernaTX, Inc. |
Chimeric polynucleotides
|
|
US11786469B2
(en)
|
2014-07-22 |
2023-10-17 |
Cheolhee WON |
Silica nanoparticle composition for delivering bioactive material or protein such as a human proteasome
|
|
WO2016014846A1
(en)
|
2014-07-23 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of intrabodies
|
|
WO2016054225A1
(en)
*
|
2014-09-30 |
2016-04-07 |
Stc.Unm |
Plasmid delivery in the treatment of cancer and other disease states
|
|
FI3834823T3
(fi)
|
2014-11-05 |
2024-04-02 |
Cartesian Therapeutics Inc |
Menetelmiä ja koostumuksia liittyen alhaisen hlb:n omaavien pinta-aktiivisten aineiden käyttöön rapalogin käsittävien synteettisten nanokantajien valmistuksessa
|
|
US20180110831A1
(en)
*
|
2015-03-09 |
2018-04-26 |
Stc.Unm |
Cd 47 containing porous nanoparticle supported lipid bilayers (protocells) field of the invention
|
|
WO2016172123A1
(en)
*
|
2015-04-24 |
2016-10-27 |
Colgate-Palmolive Company |
Porous protein particles as carriers for actives
|
|
JP6894423B2
(ja)
*
|
2015-07-09 |
2021-06-30 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ |
融合性リポソーム被覆多孔質ケイ素ナノ粒子
|
|
MA42502A
(fr)
|
2015-07-21 |
2018-05-30 |
Modernatx Inc |
Vaccins contre une maladie infectieuse
|
|
US11364292B2
(en)
|
2015-07-21 |
2022-06-21 |
Modernatx, Inc. |
CHIKV RNA vaccines
|
|
US10624949B1
(en)
|
2015-07-27 |
2020-04-21 |
National Technology & Engineering Solutions Of Sandia, Llc |
Methods for treating diseases related to the wnt pathway
|
|
RS63030B1
(sr)
|
2015-09-17 |
2022-04-29 |
Modernatx Inc |
Jedinjenja i kompozicije za intracelularno isporučivanje terapeutskih sredstava
|
|
ES2907486T3
(es)
*
|
2015-09-24 |
2022-04-25 |
Univ North Carolina Chapel Hill |
Métodos y composiciones para reducir metástasis
|
|
CN105174211B
(zh)
*
|
2015-10-12 |
2017-02-01 |
海南大学 |
一种具有表面增强拉曼活性银基复合纳米材料的制备方法及其所得产品和应用
|
|
EP3364950A4
(en)
|
2015-10-22 |
2019-10-23 |
ModernaTX, Inc. |
VACCINES AGAINST TROPICAL DISEASES
|
|
MD3718565T2
(ro)
|
2015-10-22 |
2022-09-30 |
Modernatx Inc |
Vaccinuri împotriva virusului respirator
|
|
AU2016342376A1
(en)
|
2015-10-22 |
2018-06-07 |
Modernatx, Inc. |
Sexually transmitted disease vaccines
|
|
WO2017070601A1
(en)
|
2015-10-22 |
2017-04-27 |
Modernatx, Inc. |
Nucleic acid vaccines for varicella zoster virus (vzv)
|
|
JP6667896B2
(ja)
*
|
2015-11-06 |
2020-03-18 |
国立研究開発法人産業技術総合研究所 |
リボ核酸固定化担体及びそれを用いたリボ核酸の分離回収方法
|
|
CA3007955A1
(en)
|
2015-12-10 |
2017-06-15 |
Modernatx, Inc. |
Lipid nanoparticles for delivery of therapeutic agents
|
|
JP7114465B2
(ja)
|
2015-12-22 |
2022-08-08 |
モデルナティエックス インコーポレイテッド |
薬剤の細胞内送達のための化合物および組成物
|
|
WO2017112943A1
(en)
|
2015-12-23 |
2017-06-29 |
Modernatx, Inc. |
Methods of using ox40 ligand encoding polynucleotides
|
|
WO2017120504A1
(en)
*
|
2016-01-08 |
2017-07-13 |
Durfee Paul N |
Osteotropic nanoparticles for prevention or treatment of bone metastases
|
|
CA3010711A1
(en)
*
|
2016-01-08 |
2017-07-13 |
The Regents Of The University Of California |
Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery
|
|
WO2017120612A1
(en)
|
2016-01-10 |
2017-07-13 |
Modernatx, Inc. |
Therapeutic mrnas encoding anti ctla-4 antibodies
|
|
JP7093955B2
(ja)
*
|
2016-04-14 |
2022-07-01 |
スピネカー バイオサイエンシーズ， インコーポレイテッド |
治療剤の送達のためのケイ酸金属塩を含むポーラスシリコン物質
|
|
EP3235908A1
(en)
*
|
2016-04-21 |
2017-10-25 |
Ecole Normale Superieure De Lyon |
Methods for selectively modulating the activity of distinct subtypes of cells
|
|
EP3484448B1
(en)
*
|
2016-07-13 |
2025-04-09 |
President and Fellows of Harvard College |
Antigen-presenting cell-mimetic scaffolds and methods for making and using the same
|
|
EP3269444A1
(en)
*
|
2016-07-14 |
2018-01-17 |
Base4 Innovation Ltd |
Method of identifying droplets in a stack and an associated sequencer
|
|
US11583504B2
(en)
|
2016-11-08 |
2023-02-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
CN110167587A
(zh)
|
2016-11-11 |
2019-08-23 |
摩登纳特斯有限公司 |
流感疫苗
|
|
EP3551193A4
(en)
|
2016-12-08 |
2020-08-19 |
Modernatx, Inc. |
NUCLEIC ACID VACCINES AGAINST RESPIRATORY VIRUSES
|
|
LU100023B1
(en)
|
2017-01-20 |
2018-07-30 |
Luxembourg Inst Science & Tech List |
Nanocapsules and method for manufacturing thereof
|
|
CN106822916B
(zh)
*
|
2017-01-25 |
2020-02-28 |
浙江大学 |
一种pH敏感的纳米化Bcl-2选择性抑制剂的制备方法及产物和应用
|
|
WO2018140826A1
(en)
*
|
2017-01-27 |
2018-08-02 |
The Methodist Hospital |
Core/shell structure platform for immunotherapy
|
|
US11129796B2
(en)
|
2017-02-06 |
2021-09-28 |
Lemonex Inc. |
Physiologically active substance carrier
|
|
WO2018160865A1
(en)
|
2017-03-01 |
2018-09-07 |
Charles Jeffrey Brinker |
Active targeting of cells by monosized protocells
|
|
WO2018170270A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Varicella zoster virus (vzv) vaccine
|
|
US11752206B2
(en)
|
2017-03-15 |
2023-09-12 |
Modernatx, Inc. |
Herpes simplex virus vaccine
|
|
CA3056133A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Crystal forms of amino lipids
|
|
MA47787A
(fr)
|
2017-03-15 |
2020-01-22 |
Modernatx Inc |
Vaccin contre le virus respiratoire syncytial
|
|
ES3020935T3
(en)
|
2017-03-15 |
2025-05-23 |
Modernatx Inc |
Lipid nanoparticle formulation
|
|
WO2018170245A1
(en)
|
2017-03-15 |
2018-09-20 |
Modernatx, Inc. |
Broad spectrum influenza virus vaccine
|
|
KR20190132405A
(ko)
|
2017-03-15 |
2019-11-27 |
모더나티엑스, 인크. |
치료제의 세포내 전달을 위한 화합물 및 조성물
|
|
US12077501B2
(en)
|
2017-06-14 |
2024-09-03 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
|
WO2018232357A1
(en)
|
2017-06-15 |
2018-12-20 |
Modernatx, Inc. |
Rna formulations
|
|
US11007516B1
(en)
|
2017-06-19 |
2021-05-18 |
National Technology & Engineering Solutions Of Sandia, Llc |
Tunable metal-organic framework compositions and methods thereof
|
|
JP6967810B2
(ja)
*
|
2017-07-28 |
2021-11-17 |
レモネックス インコーポレイテッドLemonex Inc. |
肝癌の予防または治療用の薬学的組成物
|
|
WO2019046809A1
(en)
|
2017-08-31 |
2019-03-07 |
Modernatx, Inc. |
METHODS OF MANUFACTURING LIPID NANOPARTICLES
|
|
KR102152348B1
(ko)
|
2017-09-05 |
2020-09-08 |
주식회사 레모넥스 |
세포 운명 조절용 조성물
|
|
WO2019050283A1
(ko)
*
|
2017-09-05 |
2019-03-14 |
주식회사 레모넥스 |
세포 운명 조절용 조성물
|
|
US10653767B2
(en)
|
2017-09-14 |
2020-05-19 |
Modernatx, Inc. |
Zika virus MRNA vaccines
|
|
US10933027B1
(en)
*
|
2017-09-25 |
2021-03-02 |
National Technology & Engineering Solutions Of Sandia, Llc |
Expanded pore particles and delivery methods thereof
|
|
CN107952076A
(zh)
*
|
2017-11-07 |
2018-04-24 |
徐州医科大学 |
一种多囊脂质体/多孔碳纳米复合物、制备方法及应用
|
|
EP3710065B1
(en)
*
|
2017-11-13 |
2024-08-21 |
Politecnico Di Torino |
Biomimetic non-immunogenic nanoassembly for the antitumor therapy
|
|
US11661599B1
(en)
|
2017-12-14 |
2023-05-30 |
National Technology & Engineering Solutions Of Sandia, Llc |
CRISPR-Cas based system for targeting single-stranded sequences
|
|
WO2019133884A1
(en)
|
2018-01-01 |
2019-07-04 |
The Regents Of The University Of California |
Scale up synthesis of silicasome nanocarriers
|
|
WO2019148101A1
(en)
|
2018-01-29 |
2019-08-01 |
Modernatx, Inc. |
Rsv rna vaccines
|
|
KR102017110B1
(ko)
|
2018-03-08 |
2019-09-02 |
한국화학연구원 |
구역화된 간소엽 모사체 및 이를 이용한 구역별 간독성 평가방법
|
|
US20200208177A1
(en)
*
|
2018-04-18 |
2020-07-02 |
Ligandal, Inc. |
Methods and compositions for genome editing
|
|
EP3784252A4
(en)
*
|
2018-04-18 |
2022-03-16 |
Oisin Biotechnologies, Inc. |
FUSOGENIC LIPID DNANOPARTICLES AND METHODS FOR THEIR PRODUCTION AND USE IN TARGET CELL SPECIFIC MANUFACTURE OF A THERAPEUTIC PROTEIN AND TREATMENT OF A TARGET CELL RELATED DISEASE, CONDITION OR DISORDER
|
|
EP3794132A1
(en)
|
2018-05-18 |
2021-03-24 |
F. Hoffmann-La Roche AG |
Targeted intracellular delivery of large nucleic acids
|
|
US11045554B1
(en)
|
2018-06-22 |
2021-06-29 |
National Technology & Engineering Solutions Of Sandia, Llc |
Lipid-coated particles for treating viral infections
|
|
US12343406B2
(en)
*
|
2018-08-06 |
2025-07-01 |
Lemonex Inc. |
Immunoreactant carrier
|
|
WO2020037530A1
(en)
*
|
2018-08-22 |
2020-02-27 |
Waterstone Pharmaceuticals (Wuhan) Co., Ltd. |
Crystalline form of compound and uses thereof in medicine
|
|
AU2019345067A1
(en)
|
2018-09-19 |
2021-04-08 |
Modernatx, Inc. |
High-purity peg lipids and uses thereof
|
|
WO2020061367A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
US12151029B2
(en)
|
2018-09-19 |
2024-11-26 |
Modernatx, Inc. |
PEG lipids and uses thereof
|
|
WO2020061457A1
(en)
|
2018-09-20 |
2020-03-26 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
|
WO2020068798A1
(en)
|
2018-09-24 |
2020-04-02 |
Guo Jimin |
Living mammalian cells modified with functional modular nanoparticles
|
|
KR20200051916A
(ko)
*
|
2018-11-05 |
2020-05-14 |
주식회사 메디포럼제약 |
고세렐린을 포함하는 실리카 하이드로겔 조성물
|
|
WO2020138907A2
(ko)
*
|
2018-12-24 |
2020-07-02 |
고려대학교 산학협력단 |
다양한 표면공정을 통한 3차원 신경세포체 형성 및 신경 돌기 생성이 가능한 구조체 제작
|
|
IT201900001009A1
(it)
|
2019-01-23 |
2020-07-23 |
Torino Politecnico |
Vettore nanoporoso biomimetico comprendente un inibitore diretto verso la forma nativa della proteina IDH2
|
|
US11351242B1
(en)
|
2019-02-12 |
2022-06-07 |
Modernatx, Inc. |
HMPV/hPIV3 mRNA vaccine composition
|
|
JP7320303B2
(ja)
*
|
2019-02-22 |
2023-08-03 |
レモネックス インコーポレイテッド |
免疫活性もしくは癌の予防または治療用の医薬組成物
|
|
US12208164B2
(en)
|
2019-02-28 |
2025-01-28 |
Unm Rainforest Innovations |
Modular metal-organic polyhedra superassembly compositions
|
|
WO2020190750A1
(en)
|
2019-03-15 |
2020-09-24 |
Modernatx, Inc. |
Hiv rna vaccines
|
|
GB201904337D0
(en)
*
|
2019-03-28 |
2019-05-15 |
Sisaf Ltd |
A delivery system
|
|
EP3714879A1
(en)
|
2019-03-28 |
2020-09-30 |
Sisaf Ltd |
Structured encapsulated silicon-containing particles
|
|
GB201904336D0
(en)
|
2019-03-28 |
2019-05-15 |
Sisaf Ltd |
A delivery system
|
|
GB201904334D0
(en)
|
2019-03-28 |
2019-05-15 |
Sisaf Ltd |
Carrier system for preparing herbaceous extracts
|
|
WO2020200472A1
(en)
*
|
2019-04-05 |
2020-10-08 |
Biontech Rna Pharmaceuticals Gmbh |
Preparation and storage of liposomal rna formulations suitable for therapy
|
|
US12377118B2
(en)
*
|
2019-08-09 |
2025-08-05 |
Case Western Reserve University |
Nanoparticle constructs for systemic co-delivery of anti-tumor agents
|
|
CA3155015A1
(en)
|
2019-09-19 |
2021-03-25 |
Modernatx, Inc. |
Carbonate containing lipid compounds and compositions for intracellular delivery of therapeutic agents
|
|
MX2022003269A
(es)
|
2019-09-19 |
2022-07-04 |
Modernatx Inc |
Compuestos lipidicos de cola ramificada y composiciones para la administracion intracelular de agentes terapeuticos.
|
|
TWI874791B
(zh)
|
2020-02-18 |
2025-03-01 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
AU2021224588B2
(en)
|
2020-02-18 |
2024-07-18 |
Gilead Sciences, Inc. |
Antiviral compounds
|
|
TWI794742B
(zh)
|
2020-02-18 |
2023-03-01 |
美商基利科學股份有限公司 |
抗病毒化合物
|
|
AU2021236234A1
(en)
|
2020-03-11 |
2022-10-06 |
Selecta Biosciences, Inc. |
Methods and compositions related to synthetic nanocarriers
|
|
CN115348873B
(zh)
*
|
2020-03-26 |
2025-04-29 |
北京脑科学与类脑研究中心 |
氨基酸介导的基因递送及其用途
|
|
EP4125816A4
(en)
*
|
2020-04-01 |
2024-01-10 |
University of Cincinnati |
MATERIALS AND METHODS FOR CANCER THERAPY TARGETING AN IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT
|
|
US11433121B1
(en)
*
|
2020-04-03 |
2022-09-06 |
National Technology & Engineering Solutions Of Sandia, Llc |
Lipid composition for the delivery of therapeutic cargos
|
|
CN113713115B
(zh)
*
|
2020-05-22 |
2023-11-24 |
青岛科技大学 |
一种采用碳多孔材料构建抗癌载药系统的方法
|
|
GB2600704A
(en)
*
|
2020-11-04 |
2022-05-11 |
Sumitomo Chemical Co |
Nanoparticle
|
|
WO2022115075A1
(en)
*
|
2020-11-30 |
2022-06-02 |
Ege Üni̇versi̇tesi̇ |
Targeted nanoparticles carrying dual drugs in the treatment of melanoma
|
|
US11524023B2
(en)
|
2021-02-19 |
2022-12-13 |
Modernatx, Inc. |
Lipid nanoparticle compositions and methods of formulating the same
|
|
CN112870387B
(zh)
*
|
2021-02-26 |
2023-08-29 |
中山大学孙逸仙纪念医院 |
一种磁性纳米药物载体及其制备方法和应用
|
|
CN113149023B
(zh)
*
|
2021-03-11 |
2023-05-02 |
昆明理工大学 |
一种介孔二氧化硅纳米颗粒经皮递送低共熔体系制备方法
|
|
WO2022192674A1
(en)
*
|
2021-03-11 |
2022-09-15 |
The Trustees Of The University Of Pennsylvania |
Targeted therapeutic lipid nanoparticles and methods of use
|
|
JP7688152B2
(ja)
|
2021-04-16 |
2025-06-03 |
ギリアード サイエンシーズ， インコーポレイテッド |
アミドを使用してカルバヌクレオシドを調製する方法
|
|
CN113082226B
(zh)
*
|
2021-04-27 |
2023-12-15 |
山东中医药大学 |
一种载药纳米笼的制备方法与其靶向循环肿瘤细胞释放雷公藤甲素的应用
|
|
JP7719954B2
(ja)
|
2021-08-18 |
2025-08-06 |
ギリアード サイエンシーズ， インコーポレイテッド |
リン脂質化合物並びにその製造方法及び使用方法
|
|
CN113735350B
(zh)
*
|
2021-09-23 |
2023-01-24 |
深圳市水务规划设计院股份有限公司 |
一种黑臭水体处理工艺及其实验装置
|
|
EP4416258A1
(en)
*
|
2021-10-13 |
2024-08-21 |
Tampere University Foundation sr |
A system for cell culturing
|
|
CN114129718B
(zh)
*
|
2021-10-19 |
2024-05-03 |
华东师范大学 |
一种用于体内自组装car-t的纳米递送系统及其制备方法和应用
|
|
WO2023161350A1
(en)
|
2022-02-24 |
2023-08-31 |
Io Biotech Aps |
Nucleotide delivery of cancer therapy
|
|
US12145890B2
(en)
|
2022-12-16 |
2024-11-19 |
Raytheon Company |
Coated (core-shell) nanoparticles for nanocomposite optical ceramics
|
|
CN116327975A
(zh)
*
|
2022-12-20 |
2023-06-27 |
中国科学院基础医学与肿瘤研究所(筹) |
一种醋酸棉酚硅脂体及其制备方法和用途
|
|
CN116327985B
(zh)
*
|
2023-02-21 |
2024-09-27 |
武汉工程大学 |
一种具有靶向超声造影成像功能的空心囊泡载药递送系统及其制备方法与应用
|
|
WO2024237645A1
(ko)
*
|
2023-05-15 |
2024-11-21 |
주식회사 엠피오스 |
소수성 약물의 서방출용 실리카 기반 나노입자, 이의 제조방법 및 이를 포함하는 경피 약물투여시스템
|
|
EP4520345A1
(en)
|
2023-09-06 |
2025-03-12 |
Myneo Nv |
Product
|